REKOM BIOTECH signs distribution agreement in India
10/7/2013
Rekom Biotech and Biogeniux signed exclusive distribution agreement for marketing Rekom Biotech’s products in India on October 7th, 2013.
This agreement marks an important step towards consolidation of Rekom Biotech in the Indian market, which is a priority objective due to the focus of Rekom on neglected diseases with a high impact on this region.
CATEGORY: NEWS
TOPICS OF INTEREST
HIGHLIGHTS
- The IDEA Agency grants Rekom Biotech an incentive to develop new recombinant antigens for the detection of Dengue
- REKOM BIOTECH implements the ISO 13485 standard
- Rekom Biotech is listed as one of the top ten leading vendors in the Insight Partners' Viral Antigens Market Forecast to 2027 report
- Vaccination vs Natural infection. A diagnostic challenge in COVID-19 asymptomatic patients, when the immunity profile is not known.
- Why choose a recombinant antigen?
